Literature DB >> 10658678

Differential expression of multiple unexpected genes during U937 cell and macrophage differentiation detected by suppressive subtractive hybridization.

M C Gingras1, J F Margolin.   

Abstract

OBJECTIVE: The objective of this study was to identify new markers of myelomonocytic differentiation using a sensitive technique that permits detection of rare differential gene expression.
MATERIALS AND METHODS: [corrected] Suppressive subtractive hybridization (SSH) was performed between the human myelomonocytic U937 cell line and 1 alpha, 25-dihydroxyvitamin D3 and transforming growth factor beta 1 differentiated U937 cells. cDNA clones with significant increased expression in differentiated U937 cells over nondifferentiated U937 cells were characterized by sequencing. [corrected] The pattern of differential gene expression obtained by SSH was confirmed by cDNA Southern and Northern blots on the undifferentiated vs. differentiated U937 cells, and by reverse transcriptase polymerase chain reaction on undifferentiated human CD34(+) stem cells isolated from bone marrow vs. peripheral blood CD14(+) mature monocytes.
RESULTS: Seven cDNAs never associated with in vitro U937 cell myelomonocytic differentiation (prolactin, 11-beta hydroxysteroid dehydrogenase [11 beta-HSD)] haptoglobin alpha (2FS)-beta precursor, GLIPR, RTVP, the RNA helicase P68, and spermidine-spermine N1-acetyltransferase) were identified. The first five of these genes previously were associated with immune function and the last two are important for intermediary metabolism. Differential expression was confirmed in CD34(+)/CD14(+) monocyte differentiation for all genes but 11 beta-HSD.
CONCLUSIONS: We identified six new markers of U937 cell differentiation, which also are differentially expressed during normal human myelomonocytic differentiation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10658678     DOI: 10.1016/s0301-472x(99)00126-5

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  13 in total

Review 1.  Subtractive hybridization--genetic takeaways and the search for meaning.

Authors:  R J Byers; J A Hoyland; J Dixon; A J Freemont
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

Review 2.  11beta-HSD1, inflammation, metabolic disease and age-related cognitive (dys)function.

Authors:  Karen E Chapman; Jonathan R Seckl
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

3.  Identification of GLIPR1 tumor suppressor as methylation-silenced gene in acute myeloid leukemia by microarray analysis.

Authors:  Yan-Hua Xiao; Xin-Hui Li; Tan Tan; Ting Liang; Hong Yi; Mao-Yu Li; Gu-Qing Zeng; Xun-Xun Wan; Jia-Quan Qu; Qiu-Yan He; Jian-Huang Li; Yu Chen; Zhi-Qiang Xiao
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-16       Impact factor: 4.553

4.  Human decidual NK cells from gravid uteri and NK cells from cycling endometrium are distinct NK cell subsets.

Authors:  H D Kopcow; M Eriksson; T F Mselle; S M Damrauer; C R Wira; C L Sentman; J L Strominger
Journal:  Placenta       Date:  2010-02-20       Impact factor: 3.481

5.  mRTVP-1, a novel p53 target gene with proapoptotic activities.

Authors:  Chengzhen Ren; Likun Li; Alexei A Goltsov; Terry L Timme; Salahaldin A Tahir; Jianxiang Wang; Laura Garza; A Craig Chinault; Timothy C Thompson
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

Review 6.  Glioma pathogenesis-related protein 1: tumor-suppressor activities and therapeutic potential.

Authors:  Timothy C Thompson
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

7.  Inhibition of HIV-1 replication by small interfering RNAs directed against glioma pathogenesis related protein (GliPR) expression.

Authors:  Gianni Capalbo; Thea Müller-Kuller; Ursula Dietrich; Dieter Hoelzer; Oliver G Ottmann; Urban J Scheuring
Journal:  Retrovirology       Date:  2010-03-31       Impact factor: 4.602

Review 8.  Glioma pathogenesis-related protein 1 performs dual functions in tumor cells.

Authors:  Junjie Wang; Zeyu Li; Fenfen Yin; Rui Zhang; Ying Zhang; Zhengxin Wang; Xiumei Sheng
Journal:  Cancer Gene Ther       Date:  2021-03-19       Impact factor: 5.987

9.  GliPR1 knockdown by RNA interference exerts anti-glioma effects in vitro and in vivo.

Authors:  Urban J Scheuring; Steffi Ritter; Daniel Martin; Gabriele Schackert; Achim Temme; Stefanie Tietze
Journal:  J Neurooncol       Date:  2021-04-15       Impact factor: 4.130

10.  Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model.

Authors:  K Tabata; S Kurosaka; M Watanabe; K Edamura; T Satoh; G Yang; E Abdelfattah; J Wang; A Goltsov; D Floryk; T C Thompson
Journal:  Gene Ther       Date:  2011-04-21       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.